Biological variation estimates for prostate specific antigen from the European Biological Variation Study; consequences for diagnosis and monitoring of prostate cancer


Carobene A., Guerra E., Locatelli M., Cucchiara V., Briganti A., Aarsand A. K. , ...Daha Fazla

CLINICA CHIMICA ACTA, cilt.486, ss.185-191, 2018 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 486
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1016/j.cca.2018.07.043
  • Dergi Adı: CLINICA CHIMICA ACTA
  • Sayfa Sayıları: ss.185-191

Özet

Background: Prostate-specific antigen (PSA) is central in the diagnosis of prostate cancer. However, high-quality biological variation (BV) estimates for PSA are scarce. Here BV estimates from the European Biological Variation Study (EuBIVAS) for total (tPSA), free (fPSA), conjugated PSA (cPSA), and percent free PSA (%fPSA) are provided.